At-Home Infusion Using Bamlanivimab in Participants With Mild to Moderate COVID-19
Clinical trial NCT04656691 · TERMINATED
Trial details
- NCT number
- NCT04656691
- Sponsor
- Daniel Griffin
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2021-04-18
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.